U.S. Packaging Stock News

American Public Education (NASDAQ:APEI) has had a rough month with its share price down 16%. We, however decided to...

The Morning Bull - US Market Morning Update Tuesday, Nov, 4 2025 US stock futures are pointing lower ahead of the opening bell as investors respond to persistent signals from the Federal Reserve about a cautious rate-cutting approach. Elevated Treasury yields and signs of ongoing manufacturing headwinds are fueling uncertainty, raising concerns that higher borrowing costs could weigh on business confidence and cool demand across the market as participants weigh the risk of a prolonged policy...

The US FDA has announced plans to streamline the approval process for gene editing therapies, aiming to speed up regulatory reviews and provide greater flexibility to companies like CRISPR Therapeutics. This regulatory initiative is expected to catalyze innovation within the gene editing sector and potentially attract additional investment into companies developing advanced therapies. We'll explore how the FDA's move to accelerate approvals could reshape CRISPR Therapeutics' investment...

Procter & Gamble (PG) stock has ticked lower recently, with investors weighing its trajectory after a stretch of share price softness. With the stock slipping around 3% over the past month, many are curious about what is next. See our latest analysis for Procter & Gamble. After a period of steady gains, Procter & Gamble’s share price momentum has cooled, with the stock marking a year-to-date share price return of -10.82%. While recent months have brought a modest pullback, the company’s...

With a price-to-sales (or "P/S") ratio of 4.7x Geron Corporation ( NASDAQ:GERN ) may be sending very bullish signals at...

DHT Holdings (DHT) just released its third quarter and year-to-date earnings, showing higher net income and earnings per share than last year. This financial update could change how investors view the company’s outlook. See our latest analysis for DHT Holdings. DHT Holdings’ solid earnings performance arrives during a strong run for investors, with the stock notching a 35.3% share price gain year-to-date and a one-year total shareholder return of 38.5%. The recent 10% share price return over...

Potential OPKO Health, Inc. ( NASDAQ:OPK ) shareholders may wish to note that the Chairman & CEO, Phillip Frost...

Trade Desk (TTD) shares have climbed about 3% in the latest session, catching the attention of investors after a period of weaker returns over the past month and past 3 months. This recent move has raised questions about what might be driving renewed interest. See our latest analysis for Trade Desk. While Trade Desk’s shares have just staged a 2.7% bounce, this comes after a steep slide that saw the share price return drop more than 57% since the start of the year. Over longer horizons,...

Wondering whether United Therapeutics is a hidden bargain or already priced for perfection? You are not alone. Let's unpack where the real value may lie. The stock has delivered a 21.8% return year-to-date and an impressive 221.9% rise over the last five years. However, the past month saw a slight 3.2% dip, signaling both robust growth and recent recalibration. United Therapeutics recently caught the market’s attention with regulatory milestones and pipeline updates fueling optimism...

Thanks in no small measure to Vanguard founder Jack Bogle, it's easy buy a low cost index fund, which should provide...

Curious about whether T. Rowe Price Group is a bargain or overpriced right now? You are not alone; it is a common question for anyone looking to spot value in financial stocks. In the last week, the stock slipped 3.1%, and it is down 10.3% year-to-date, showing that investors may be rethinking its prospects or repositioning amid shifting market conditions. News around recent regulatory shifts in asset management and industry-wide fee pressures have kept T. Rowe Price Group in the spotlight...

Wondering if Tutor Perini is a hidden gem or if the best gains are behind it? You are not alone. Many investors are re-examining its value after the incredible run up this year. The stock has soared with a year-to-date return of 182.3% and is up 160.9% over the past year, although there was a slight dip of 0.7% in just the last week. Recent headlines have spotlighted Tutor Perini’s expansion in infrastructure contracts and industry partnerships, fueling positive momentum...

Alexander’s (ALX) latest results show earnings under pressure, with net profit margin at 17.1%, down from 22.1% in the previous year. Earnings have seen a 2.5% annualized decline over the last five years. Analysts now expect a further earnings contraction of 20.1% per year over the next three years, while revenue growth is forecast at just 0.7% per year, which is significantly below the US market's typical pace of 10.5%. With shares trading at $224.51, well above the estimated fair value of...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Robert Half Inc. ( NYSE:RHI ) shareholders that were waiting for something to happen have been dealt a blow with a 26...

Curious if BJ's Wholesale Club Holdings stock could be a hidden bargain or just along for the ride? Let’s unpack what the numbers and the news are really saying about its value. While shares are up an impressive 141% over five years, recent momentum has slowed with a 3.0% dip this past week and a 2.0% slide over the last month. The stock is still holding a 4.7% gain for the year. Investors have taken notice of BJ’s recent partnership expansion with a major delivery service, signaling focus...

Arm Holdings (ARM) shares have recaptured the spotlight following their sustained rally this past month. Investors are keeping a close eye on the semiconductor designer's latest performance. Activity around ARM remains closely watched as tech stocks draw fresh attention. See our latest analysis for Arm Holdings. This latest surge follows a wave of renewed optimism around semiconductors, with Arm Holdings’ 1-month share price return climbing over 10%. Even when accounting for some short-term...

Organon (NYSE:OGN) has been thrust into the spotlight after CEO Kevin Ali resigned, following an audit committee investigation into alleged channel stuffing. Investors are watching closely as a new leadership team takes charge during this turbulent period. See our latest analysis for Organon. After a string of management shake-ups and controversy over alleged channel stuffing, Organon's share price has struggled, falling sharply with a 39% drop over the last month and a year-to-date share...

Iovance Biotherapeutics (IOVA) recently shared interim results from its Phase 2 IOV-LUN-202 study. The company highlighted a 26% objective response rate and durable disease control in advanced nonsquamous non-small cell lung cancer. See our latest analysis for Iovance Biotherapeutics. Despite the encouraging clinical progress and regulatory momentum from the recent Phase 2 trial update, Iovance Biotherapeutics’ share price return has remained under pressure, falling 17% over the past month...

The board of LKQ Corporation ( NASDAQ:LKQ ) has announced that it will pay a dividend of $0.30 per share on the 4th of...

BlackRock (BLK) shares have slipped around 1% in the past day, adding to a steady slide over the past month. Investors are keeping tabs on possible factors that could be driving this recent weakness in the price. See our latest analysis for BlackRock. BlackRock has seen its share price slip recently, but the long-term picture is still positive. The stock is up 10% in total shareholder return over the past year and an impressive 70% over three years, even as near-term momentum has faded a bit...

Luckin Coffee (OTCPK:LKNC.Y) shares slipped after a dip of roughly 1% as investors reacted to the latest trading session. The stock's modest movement comes amid consistent annual revenue and net income growth for the company. See our latest analysis for Luckin Coffee. Luckin Coffee's share price has cooled off a bit in the past month, but the bigger story is its momentum. With a 47.1% share price return so far this year and an impressive 61.3% total shareholder return for the past 12 months,...

Shares of Bristol-Myers Squibb jumped 4% after the company reported third-quarter results that topped forecasts. The company increased its full-year revenue guidance and highlighted strong momentum across its Growth Portfolio. See our latest analysis for Bristol-Myers Squibb. Bristol-Myers Squibb’s recent 4% gain reflects renewed optimism after solid quarterly results, a guidance boost, and updates from a packed pipeline. Despite this bounce, momentum has not carried through long term. The...

Sandisk (SNDK) caught the attention of traders after a recent Power Inflow alert suggested renewed buying interest from both institutions and individual investors. This followed an earlier drop in the share price. See our latest analysis for Sandisk. The Power Inflow alert came as Sandisk’s 1-day share price return jumped 3.85 percent, capping off a remarkable 61.21 percent return for the month and an eye-catching 475 percent rise year-to-date. This surge signals renewed momentum, as...